ACE and acute kidney injury: Based on a combination of claims data and laboratory data, we identified the following five AKI-associated factors: prior treatment with ACE inhibitors/ARBs or carbapenem, concomitant administration of catecholamines or immunosuppressants, and ≥ 3.52 mg/kg/day of L-AMB dosing.